Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (571-580 of 651) with videos related to

Pageof 66
Sort By:
Leukemia|May 14, 2024
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocolsMartin Neumann, Thomas Beder, Lorenz Bastian, et al.
Blood|January 14, 2025
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trialMarc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Journal of Hematology & Oncology|December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemiaNicole Bäumer, Annika Scheller, Lisa Wittmann, et al.
Nature Medicine|December 13, 2016
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
Nature Genetics|November 26, 2024
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotypeAino-Maija Leppä, Karen Grimes, Hyobin Jeong, et al.
Journal for Immunotherapy of Cancer|October 8, 2024
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myelomaJan H Frenking, Xiang Zhou, Vivien Wagner, et al.
Blood Advances|April 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myelomaJan Hendrik Frenking, Xiang Zhou, Kai Rejeski, et al.
Blood|August 1, 2025
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cellsCornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, et al.
Pageof 66

Showing results (571-580 of 651) with videos related to

Sort By:
Pageof 66
Leukemia|May 14, 2024
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocolsMartin Neumann, Thomas Beder, Lorenz Bastian, et al.
Blood|January 14, 2025
Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trialMarc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.
Blood Advances|January 23, 2023
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemiaFalk Heidenreich, Bose Falk, Henning Baldauf, et al.
Journal of Hematology & Oncology|December 2, 2022
Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemiaNicole Bäumer, Annika Scheller, Lisa Wittmann, et al.
Nature Medicine|December 13, 2016
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemiaStefanie Göllner, Thomas Oellerich, Shuchi Agrawal-Singh, et al.
Nature Genetics|November 26, 2024
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotypeAino-Maija Leppä, Karen Grimes, Hyobin Jeong, et al.
Journal for Immunotherapy of Cancer|October 8, 2024
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myelomaJan H Frenking, Xiang Zhou, Vivien Wagner, et al.
Blood Advances|April 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myelomaJan Hendrik Frenking, Xiang Zhou, Kai Rejeski, et al.
Blood|August 1, 2025
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cellsCornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, et al.
Pageof 66